# Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC

> **NCT01259193** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sorafenib and Zoledronic Acid

## Key facts

- **NCT ID:** NCT01259193
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-07
- **Final completion:** 2012-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259193, "Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01259193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*